114 related articles for article (PubMed ID: 27064898)
1. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
2. Real-world Assessment of Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma with or Without Sarcomatoid Features Treated with First-line Systemic Therapies.
Sawaya GB; Dragomir A; Wood LA; Kollmannsberger C; Basappa NS; Kapoor A; Soulières D; Finelli A; Heng DYC; Castonguay V; Canil C; Winquist E; Graham J; Bjarnason GA; Bhindi B; Lalani AK; Pouliot F; Breau RH; Saleh R; Tanguay S
Eur Urol Oncol; 2024 Jun; 7(3):570-580. PubMed ID: 38097481
[TBL] [Abstract][Full Text] [Related]
3. The results of surgery for renal cell carcinoma metastases of the pancreas.
Riemenschneider KA; Farooqui W; Penninga L; Storkholm JH; Hansen CP
Scand J Gastroenterol; 2024 Mar; 59(3):354-360. PubMed ID: 38042983
[TBL] [Abstract][Full Text] [Related]
4. Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.
May M; Brookman-May S; Hoschke B; Gilfrich C; Kendel F; Baxmann S; Wittke S; Kiessig ST; Miller K; Johannsen M
Cancer Immunol Immunother; 2010 May; 59(5):687-95. PubMed ID: 19876628
[TBL] [Abstract][Full Text] [Related]
5. Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
Guram K; Huang J; Mouchati C; Abdallah N; Jani C; Navani V; Xie W; El Zarif T; Adib E; Gebrael G; Agarwal N; Li H; Labaki C; Labban M; Ruiz Morales JM; Choueiri TK; Chin Heng DY; Mittal A; Hansen AR; Rose BS; McKay RR
Cancer; 2024 Jun; 130(11):2003-2013. PubMed ID: 38297953
[TBL] [Abstract][Full Text] [Related]
6. Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b).
Stellato M; Santini D; Verzoni E; De Giorgi U; Pantano F; Casadei C; Fornarini G; Maruzzo M; Sbrana A; Di Lorenzo G; Soraru M; Naglieri E; Buti S; De Vivo R; Napolitano A; Vignani F; Mucciarini C; Grillone F; Roviello G; Di Napoli M; Procopio G
Front Oncol; 2021; 11():682449. PubMed ID: 34168997
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma.
Malleo G; Salvia R; Maggino L; Marchegiani G; D'Angelica M; DeMatteo R; Kingham P; Pulvirenti A; Sereni E; Jarnagin WR; Bassi C; Allen PJ; Butturini G
Ann Surg Oncol; 2021 Jun; 28(6):3100-3108. PubMed ID: 33575870
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
Tappero S; Barletta F; Piccinelli ML; Cano Garcia C; Incesu RB; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; Briganti A; de Cobelli O; Chun FKH; Graefen M; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
Urol Oncol; 2024 Jan; 42(1):22.e23-22.e31. PubMed ID: 37775340
[TBL] [Abstract][Full Text] [Related]
9. Natural history of bone-only metastasis in renal cell carcinoma.
Tang B; Duan R; Fan Z; Yan X; Li S; Zhou L; Li J; Xu H; Mao L; Lian B; Wang X; Bai X; Wei X; Li C; Cui C; Si L; Chi Z; Guo J; Sheng X
Urol Oncol; 2024 Apr; 42(4):119.e17-119.e22. PubMed ID: 38383241
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
Duarte C; Hu J; Beuselinck B; Panian J; Weise N; Dizman N; Collier KA; Rathi N; Li H; Elias R; Martinez-Chanza N; Rose TL; Harshman LC; Gopalakrishnan D; Vaishampayan U; Zakharia Y; Narayan V; Carneiro BA; Mega A; Singla N; Meguid C; George S; Brugarolas J; Agarwal N; Mortazavi A; Pal S; McKay RR; Lam ET
EClinicalMedicine; 2023 Jun; 60():102018. PubMed ID: 37304495
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic resection for metastasis from renal cell carcinoma: A single institution experience and meta-analysis of survival outcomes.
Hajibandeh S; Hajibandeh S; Romman S; Ghassemi N; Evans D; Laing RW; Durkin D; Athwal TS
Pancreatology; 2024 Feb; 24(1):160-168. PubMed ID: 38012888
[TBL] [Abstract][Full Text] [Related]
12. The Diagnosis, Treatment, and Follow-up of Renal Cell Carcinoma.
Doehn C; Grünwald V; Steiner T; Follmann M; Rexer H; Krege S
Dtsch Arztebl Int; 2016 Sep; 113(35-36):590-6. PubMed ID: 27658472
[TBL] [Abstract][Full Text] [Related]
13. Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial.
Pishvaian MJ; Blais EM; Brody JR; Lyons E; DeArbeloa P; Hendifar A; Mikhail S; Chung V; Sahai V; Sohal DPS; Bellakbira S; Thach D; Rahib L; Madhavan S; Matrisian LM; Petricoin EF
Lancet Oncol; 2020 Apr; 21(4):508-518. PubMed ID: 32135080
[TBL] [Abstract][Full Text] [Related]
14. Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study.
Beisland C; Johannesen TB; Klepp O; Axcrona U; Torgersen KM; Kowalski J; Solli O; Sandin R; Oldenburg J
Onco Targets Ther; 2017; 10():371-385. PubMed ID: 28144152
[TBL] [Abstract][Full Text] [Related]
15. Bone metastases affect prognosis but not effectiveness of third-line targeted therapies in patients with metastatic renal cell carcinoma.
Iacovelli R; Santini D; Rizzo M; Felici A; Santoni M; Verzoni E; Masini C; Massari F; Calvani N; Mosca A; Procopio G
Can Urol Assoc J; 2015; 9(7-8):263-7. PubMed ID: 26316911
[TBL] [Abstract][Full Text] [Related]
16. Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy.
Choi SK; Min GE; Jeon SH; Lee HL; Chang SG; Yoo KH
Mol Clin Oncol; 2013 Mar; 1(2):365-368. PubMed ID: 24649176
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal metastases in renal cell carcinoma: A retrospective multicenter GETUG (Groupe d'Étude des Tumeurs Uro-Génitales) study.
Carneiro F; Vinceneux A; Larroquette M; Rony M; Carril L; Laguerre B; Blazevic I; Bartelemy P; Teyssonneau D; Goujon M; Linassier C; Thiery-Vuillemin A; Roubaud G; Mourey L; Albiges L; Gravis G; Gross-Goupil M; Cancel M
Eur J Cancer; 2024 Mar; 199():113534. PubMed ID: 38241819
[TBL] [Abstract][Full Text] [Related]
18. Tumour Evolution and Seed and Soil Mechanism in Pancreatic Metastases of Renal Cell Carcinoma.
Sellner F; Thalhammer S; Klimpfinger M
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809634
[TBL] [Abstract][Full Text] [Related]
19. [Electromagnetic procedures in the treatment of pancreatic cancer: eminent or resentful?].
Dank M; Herold M; Garay MT; Gajdácsi J; Herold Z; Szász MA
Magy Onkol; 2023 Sep; 67(3):194-201. PubMed ID: 38484317
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Renal Cell Carcinoma to the Pancreas: A Review.
Cheng SK; Chuah KL
Arch Pathol Lab Med; 2016 Jun; 140(6):598-602. PubMed ID: 27232353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
